You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rigosertib

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma Trial in Salzburg (Rigosertib Oral Capsules / Rigosertib Intravenous)

Recruiting
  • Epidermolysis Bullosa Dystrophica
  • Squamous Cell Carcinoma
  • Rigosertib Oral Capsules / Rigosertib Intravenous
  • Salzburg, Austria
    EB House Austria/Dept. of Dermatology University Hospital
Nov 3, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Rigosertib
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 28, 2023

NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Feb 8, 2022

Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)

Recruiting
  • Recessive Dystrophic Epidermolysis Bullosa
  • Rigosertib Sodium
  • Quality-of-Life Assessment
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Gilbert, Arizona
  • +12 more
Jun 15, 2021

Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)

Terminated
Has Results
  • Leukemia
  • +3 more
  • Rigosertib
  • Questionnaire
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 5, 2020

Myelodysplastic Syndrome Trial in New York (rigosertib)

Withdrawn
  • Myelodysplastic Syndrome
  • rigosertib
  • New York, New York
    Columbia University Medical Center
Jun 29, 2020

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • rigosertib
  • +2 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • rigosertib sodium
  • Stanford, California
  • +34 more
Jun 29, 2020

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +8 more
Nov 14, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

Withdrawn
  • Myelodysplastic Syndrome
  • SyB C-1101 and Azacytidine
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB L-1101
  • Nagoya, Aichi, Japan
  • +2 more
Nov 14, 2022

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • ON 01910.Na
  • Scottsdale, Arizona
  • +86 more
Jun 29, 2020

Healthy Trial in Madison (rigosertib)

Completed
  • Healthy
  • rigosertib
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
Jun 22, 2017

Myelodysplastic Syndrome, MDS, Trisomy 8 Trial in United States (rigosertib)

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • rigosertib
  • Scottsdale, Arizona
  • +4 more
Jun 22, 2017

Solid Tumor Trial in Denver (rigosertib)

Completed
  • Solid Tumor
  • rigosertib
  • Denver, Colorado
    University of Colorado at Denver Health and Sciences
Jun 22, 2017

Head and Neck Tumors, Carcinoma, Squamous Cell Trial in United States (oral rigosertib, cisplatin, Radiotherapy)

Completed
  • Head and Neck Neoplasms
  • Carcinoma, Squamous Cell
  • oral rigosertib
  • +2 more
  • Aurora, Colorado
  • +3 more
Jun 22, 2017

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Myeloproliferative Disease Trial in Houston (rigosertib)

Completed
  • Acute Myelocytic Leukemia
  • +3 more
  • rigosertib
  • Houston, Texas
    University of Texas M. D. Anderson Cancer Center
Jun 22, 2017

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelocytic Leukemia Trial in New York (ON 01910.Na)

Completed
  • Acute Myelocytic Leukemia
  • +4 more
  • ON 01910.Na
  • New York, New York
    Mount Sinai Medical Center
Jan 9, 2018

Advanced Cancer, Solid Tumors, Cancer Trial in New York (rigosertib sodium)

Completed
  • Advanced Cancer
  • +3 more
  • rigosertib sodium
  • New York, New York
    Mount Sinai School of Medicine
Jun 22, 2017

Ovarian Cancer Trial in Indianapolis (ON 01910.Na)

Completed
Has Results
  • Ovarian Cancer
  • ON 01910.Na
  • Indianapolis, Indiana
    St. Vincent Gynecologic Oncology
Jun 22, 2017

Solid Tumors, Advanced Cancer, Cancer Trial in The Bronx (rigosertib sodium)

Completed
  • Solid Tumors
  • +3 more
  • rigosertib sodium
  • The Bronx, New York
    Albert Einstein Cancer Center
Jun 22, 2017